TrialClinical and translational science2022

Evaluation of the abuse potential of difelikefalin, a selective kappa-opioid receptor agonist, in recreational polydrug users.

Megan J Shram et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.